Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABC.L Regulatory News (ABC)

  • There is currently no data for ABC

Form 8.5 (EPT/RI)- Abcam plc

8 May 2018 08:31

RNS Number : 3322N
JPMorgan Securities Plc
08 May 2018
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

J.P. Morgan Securities Plc

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Abcam plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Corporate Broker and Financial Advisor to Abcam plc

(d) Date dealing undertaken:

04 May 2018

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

Yes, Horizon Discovery Group plc

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received (GBP)

Lowest price per unit paid/received (GBP)

Ordinary Shares

Purchases

 

Sales

81,263

 

115,275

12.8450

 

12.8600

12.6506

 

12.6500

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

(GBP)

Ordinary Shaes

Equity Swaps

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Long

 

 

 

 

 

 

 

Short

 

 

 

 

 

 

 

 

 

 

 

85,998

 503

 320

 1,200

 20

 256

 296

 

256

 12,893

 2,917

 721

 836

 9,272

 9,392

 321

 7,569

 10,709

 1,243

 5,040

12.6500

12.6645

12.7159

12.7397

12.7790

12.7825

12.8090

 

12.6506

12.6588

12.6809

12.6963

12.7034

12.7077

12.7093

12.7103

12.7177

12.7217

12.7372

12.7660

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

(GBP)

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit (GBP)

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

(GBP)

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

(GBP)

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

Date of disclosure:

08 May 2018

Contact name:

Alwyn Basch

Telephone number:

020 7742 7407

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FERLIFVDEIITIIT
Date   Source Headline
29th Oct 20212:42 pmRNSTotal Voting Rights
27th Oct 20217:00 amRNSCompletion of BioVision Acquisition
12th Oct 20214:46 pmRNSHolding(s) in Company
11th Oct 20214:21 pmRNSBlock listing Interim Review
6th Oct 202110:35 amRNSHolding(s) in Company
24th Sep 20214:03 pmRNSDirector/PDMR Shareholding
13th Sep 202112:00 pmRNSInterim results for the 6 and 12 month periods
1st Sep 20214:02 pmRNSTotal Voting Rights
1st Sep 202112:00 pmRNSTransition Report on 20-F and Notice of Results
17th Aug 20217:52 pmEQSThis is a test - Please ignore
13th Aug 20217:00 amRNSDirectorate Change
2nd Aug 202112:57 pmRNSTotal Voting Rights
2nd Aug 20217:00 amRNSAbcam to Acquire BioVision for $340 million
9th Jul 20212:34 pmRNSBlock listing Interim Review
1st Jul 20214:22 pmRNSTotal Voting Rights
1st Jul 20214:03 pmRNSResult of General Meeting
1st Jul 202112:00 pmRNSPre-Close Trading Update
2nd Jun 20219:54 amRNSTotal Voting Rights
2nd Jun 20218:30 amRNSNotice of Year End Change and General Meeting
19th May 20217:00 amRNSDirectorate Change
6th May 20217:00 amRNSTotal Voting Rights
1st Apr 20213:11 pmRNSTotal Voting Rights
12th Mar 20212:55 pmRNSDirector/PDMR Shareholding
11th Mar 202111:46 amRNSDirector/PDMR Shareholding - Replacement
10th Mar 20214:50 pmRNSDirector/PDMR Shareholding
8th Mar 202112:02 pmRNSInterim Results for 6 months ended 31 Dec 2020
1st Mar 20215:08 pmRNSTotal Voting Rights
26th Feb 20217:00 amRNSNotice of Results
17th Feb 202112:00 pmRNSAbcam presenting at the SVB Leerink Conference
4th Feb 20213:24 pmRNSDirector/PDMR Shareholding
1st Feb 20219:27 amRNSTotal Voting Rights
28th Jan 20217:00 amRNSDirectorate Change
14th Jan 20213:26 pmRNSHolding(s) in Company
11th Jan 202112:00 pmRNSHalf year trading update
4th Jan 202111:03 amRNSTotal Voting Rights
21st Dec 20207:00 amRNSAbcam plc presenting at JPM Healthcare Conference
21st Dec 20207:00 amRNSNotification of Trading Update
17th Dec 20209:35 amRNSHolding(s) in Company
4th Dec 20202:32 pmRNSResult of AGM
1st Dec 20204:46 pmRNSTotal Voting Rights
4th Nov 202010:33 amRNSDirector/PDMR Shareholding
3rd Nov 20201:30 pmRNSConsultation on 2020 LTIP Awards
3rd Nov 20201:30 pmRNSAnnual Report, Impact Report and Notice of AGM
2nd Nov 202010:49 amRNSTotal Voting Rights
26th Oct 20203:45 pmRNSAbcam Announces Closing of Offering
23rd Oct 20207:00 amRNSExercise of Over-allotment Option
22nd Oct 20207:00 amRNSPricing of Offering on NASDAQ
19th Oct 202012:15 pmRNSOffering and Application to List on Nasdaq
5th Oct 20207:01 amRNSRegistration Statement for Proposed Offering Filed
5th Oct 20207:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.